Patent details

Basic Information

Publication number:

EP2594285

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP121872980

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Lyophilized therapeutic peptibody formulations

French Title of Invention:

Formulations peptide-anticorps thérapeutiques lyophilisées

German Title of Invention:

Lyophilisierte therapeutische Peptidkörperformulierungen

SPC Number:

Dates

Filing date:

20/04/2007

Grant date:

10/08/2016

EP Publication Date:

10/08/2016

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

22/05/2013

EP B1 Publication Date:

10/08/2016

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

20/04/2017

Expiration date:

20/04/2027

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

20/04/2007

 

 

Name:

Amgen Inc.

Address:

One Amgen Center Drive, Thousand Oaks, CA 91320-1799, United States (US)

Inventor

1

Name:

Callahan William J.

Address:

United States (US)

2

Name:

Remmele Richard L., Jr.

Address:

United States (US)

3

Name:

Liu Dingjiang

Address:

United States (US)

4

Name:

Ratnaswamy Gayathri

Address:

United States (US)

5

Name:

Latypov Ramil F.

Address:

United States (US)

Priority

1

Priority Number:

793997 P

Priority Date:

21/04/2006

Priority Country:

United States (US)

2

Priority Number:

788697

Priority Date:

19/04/2007

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 39/395;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages